MiR-214 is upregulated by the thyroid hormone through direct interactions with its receptor in the promoter region, leading to repression of the target oncogene, PIM-1, and in turn, suppression of HCC cell proliferation and inhibition of tumor formation [38]. Here, TG is linked to neoplasm.